H 股股份奖励计划 2026 年[3]月[13]日 北京云迹科技股份有限公司 1 | 第一章 释 | 义 | 3 | | --- | --- | --- | | 第二章 | 本计划目的、期限和基本原则 | 7 | | 第三章 | 本计划的管理 | 8 | | 第四章 | 激励对象 11 | | | 第五章 | 资金来源和目标股份来源 | 18 | | 第六章 | 奖励股份的授予 | 24 | | 第七章 | 奖励股份的归属 | 27 | | 第八章 | 奖励股份的转让及其他权利 | 32 | | 第九章 | 资本结构重组、控制权变更及自动清算等 | 33 | | 第十章 | 本计划的变更、争议、终止及奖励股份的注销 | 35 | | 第十一章 | 其他 | 37 | 第一章 释 义 除非另有说明，以下简称在本文中作如下释义： | 名称 | 释义 | | --- | --- | | | 指根据本计划第7.8条受托人就奖励股份的归属出售 | | 实际售价 | 对应的相关目标股份，根据指令向激励对象就其获归 | | | 属的奖励股份进行分配所应付的现金价值 | | 采纳日期 | 指即本计划于股东会上获批准的日期 | ...

Group 1 - Zhipu AI (02513) saw a price increase of over 10% during trading, currently up 7.4%, following the announcement of its first closed-source model GLM-5-Turbo and a 20% price hike for its new model API [1] - Capital Airport (00694) dropped over 4% after JPMorgan downgraded its investment rating from "Neutral" to "Underweight" and cut the target price by 40% to HKD 1.8, citing structural challenges and potential selling pressure from being removed from the Hong Kong Stock Connect list [1] - Cloudwalk Technology (02670) rose over 7% after signing a strategic cooperation agreement with SF Express to define new standards for building delivery [1] Group 2 - Yiming Anke-B (01541) increased by over 8% after receiving approval for its II phase clinical study of IMM0306 for treating Primary Membranous Nephropathy [2] - WanGuo Data-SW (09698) surged over 12.6% after reporting a net revenue of RMB 11.4323 billion (USD 1.6348 billion) for the year, a 10.8% year-on-year increase, with adjusted EBITDA also up by 10.8% [2] - Automotive stocks collectively fell, with Li Auto-W (02015) down 6.24%, Xpeng Motors-W (09868) down 4.35%, and Great Wall Motors (02333) down 2.64%, amid warnings from multiple CEOs about rising chip costs [2] Group 3 - Smoore International (06969) opened slightly higher but fell 15.21% after reporting a revenue of approximately RMB 14.256 billion for 2025, a 20.8% increase, but a net profit decline of 18.5% [3] - China Cosco Shipping Energy Transportation (01138) rose 5.39% as reports indicated significant impacts on the tanker and energy markets due to ongoing Middle East conflicts [3] Group 4 - China Oriental Education (00667) increased by 6.57% after reporting a revenue of RMB 4.616 billion for 2025, a 12.1% year-on-year increase, with net profit up 47.5% [4] - Changfeng Pharmaceutical (02652) surged over 21%, currently up 9.99%, after announcing the acceptance of its IND application for a new inhalation powder for treating pulmonary arterial hypertension [4] Group 5 - Swarmer (SWMR.US) debuted on the US stock market with a staggering opening price increase of 315.4%, currently up 520%, focusing on AI-driven drone swarm control systems [5] - 36Kr (KRKR.US) rose 37.39% after reporting a total revenue of RMB 227 million for 2025, with a gross margin increase to 58% and a net profit of approximately RMB 11.42 million [5] - Space-related stocks saw active trading, with Rocket Lab (RKLB.US) up 10.21% and Planet Labs PBC (PL.US) up 10.08% [5] Group 6 - Solaris Energy Infrastructure (SEI.US) rose 10.88% after announcing agreements worth USD 620 million to add approximately 900 MW of gas turbine capacity between 2026 and 2029 [7] - Uber (UBER.US) increased by 4.19% following a partnership with NVIDIA to deploy autonomous taxi fleets in major US cities by 2027 [8] - Aiko Solar (CSIQ.US) rose 1.94% after announcing a supply agreement for a 500 MW energy storage project [8] - Atour (ATAT.US) saw a price increase of 5.98% after reporting a net revenue of approximately RMB 2.788 billion for Q4 2025, a 33.8% year-on-year increase [8]

Beijing Yunji Technology Co., Ltd. 北京雲迹科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2670） | 與本代表委任表格 | 非上市股份 | | --- | --- | | 有關的股份數目 （附註1） | H股 | | | （附註5） 普通決議案 | （附註5） 贊成 | （附註5） 反對 | 棄權 | （附註5） | | --- | --- | --- | --- | --- | --- | | 1. | 審議及批准委任張偉先生為本公司監事的議案。 | | | | | | | （附註5） 特別決議案 | （附註5） 贊成 | （附註5） 反對 | 棄權 | （附註5） | | 2. | 審議及批准採納本公司H股股份獎勵計劃的議案。 | | | | | | 3. | 審議及批准採納本公司H股股份獎勵計劃的計劃授權限額（為臨時股東會批准 此議案當日已發行股份總數的10%）的議案，須待上述第2項決議案獲通過後， | | | | | | | 方可作實。 | | | | | | 4. | 審議及批准採納服務供應商限額（為臨時股東會批准此議案當日已發行股份 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告的內容概不負責，對其準確性或完整性亦 不發表任何聲明，並明確表示，概不對因本通告全部或任何部份內容而產生或因倚賴該等內容而引致的任 何損失承擔任何責任。 Beijing Yunji Technology Co., Ltd. 北京雲迹科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2670） 臨時股東會通告 茲通告北京雲迹科技股份有限公司（「本公司」）謹定於2026年4月2日（星期四）上 午9時正以混合會議模式舉行臨時股東會（「臨時股東會」）。股東可選擇親身出席實體 臨時股東會，主要地點為中國北京市海淀區知春路6號錦秋國際大廈B區7層 －HDOS 會議室，或透過電子投票系統於網上出席臨時股東會，以審議並酌情通過下列決議 案。除另有界定者外，本通告所用詞彙與本公司日期為2026年3月13日的通函（「通 函」）所界定者具有相同涵義。 普通決議案 承董事會命 北京雲迹科技股份有限公司 董事長、執行董事兼總裁 支濤 北京，2026年3月13日 附註： 1 審議及批准委任張偉先生為本公司監事的議案。 特別決議案 – 1 – 2 審議及批准採 ...

閣下對本通函任何方面或應採取的行動如有任何疑問，應諮詢股票經紀或其他持牌證券交易商、銀行經 理、律師、專業會計師或其他專業顧問。 閣下如已售出或轉讓名下所有北京雲迹科技股份有限公司的股份，應立即將本通函連同隨附的代表委任表 格交予買主或承讓人、或經手買賣或轉讓的銀行、股票經紀或其他代理人，以便轉交買主或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函的內容概不負責，對其準確性或完整性亦 不發表任何聲明，並明確表示，概不對因本通函全部或任何部份內容而產生或因倚賴該等內容而引致的任 何損失承擔任何責任。 Beijing Yunji Technology Co., Ltd. 北京雲迹科技股份有限公司 此乃要件 請即處理 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2670） 委任監事 建議採納H股股份獎勵計劃及相關事項 建議授權董事會及╱或其授權人士辦理H股股份獎勵計劃相關事宜 及 臨時股東會通告 本公司謹訂於2026年4月2日（星期四）上午9時正以混合會議模式舉行臨時股東會。股東可選擇親身出席 實體臨時股東會，主要地點為中國北京市海淀區知春路6號錦秋國際大廈B區7層－HDOS會議室， ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 Beijing Yunji Technology Co., Ltd. 北京雲迹科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2670） 建議委任非執行董事 茲提述北京雲迹科技股份有限公司（「本公司」，連同其附屬公司統稱（「本集團」） 日期為2026年2月27日之公告，內容有關（其中包括）非執行董事辭任。 本公司董事（「董事」）會（「董事會」）謹此宣佈，根據《中華人民共和國公司法》《中 華人民共和國證券法》及《香港聯合交易所有限公司證券上市規則》（「上市規則」） 等有關法律法規以及本公司公司章程的規定，董事會建議委任王克貴先生（「王先 生」）為本公司第二屆董事會非執行董事候選人，其委任將提交本公司股東會批准 後方可做實，其董事任期將自本公司股東會批准之日起生效至第二屆董事會任期 屆滿之日止。 王先生的簡歷詳情載列如下： 王克貴先生，53歲，自2025年6月至今任安徽省人工智能產 ...

Financial Performance - Revenue for the year reached RMB 301.2 million, an increase of 23.1% compared to RMB 244.8 million in 2024[5] - The net loss attributable to equity shareholders was RMB 294.9 million, a 59.4% increase from the RMB 185.0 million loss in 2024[5] - Adjusted net loss was RMB 113.1 million, up 310.5% from RMB 27.6 million in 2024[5] - The gross profit was RMB 113.4 million, an increase from RMB 106.4 million in 2024[5] - The company reported a net loss of RMB 295.2 million for the year, a 59.6% increase in losses compared to RMB 185.0 million in 2024[45] - The pre-tax loss for the year ending December 31, 2025, was RMB 295.232 million, compared to RMB 184.963 million in 2024[84] - The company reported a basic loss per share attributable to ordinary shareholders of RMB 138.823 million for the year ending December 31, 2025, compared to RMB 58.175 million in 2024[89] Customer Growth and Market Expansion - The number of customers subscribing to HDOS increased by 925%[6] - The number of customers subscribing to the HDOS product surged by 925%, reaching 2,430 by December 31, 2025, compared to 237 in 2024[15] - The hotel sector contributed 81.0% of the company's total revenue in 2025, with plans to expand services and introduce new products like noodle-making and stir-frying robots[18] - The company aims to diversify revenue sources by targeting the B2C market, with the number of containers operated through its online mall in hotel scenarios reaching 2,231 by December 31, 2025[18] Technology and Product Development - The AI digital system, HDOS, has enhanced the cognitive, interactive, and decision-making capabilities of intelligent agents[9] - The new generation of 3D visual perception systems achieved a classification accuracy of 97.87% with an inference delay of under 10 milliseconds[10] - The vertical voice intelligence technology has been applied in thousands of hotels, processing over 100 million user interaction data[11] - Intent understanding accuracy reached over 98.5% and speech recognition error rate is below 5%[12] - The company has commercialized its industrial AI diagnostic solution, reducing diagnostic time from 40-120 minutes to 9-18 minutes, achieving a diagnostic completion rate of 97.2%[13] - The company plans to enhance its product and service offerings to meet diverse industry needs, including context-aware interaction modules and versatile robotic arms[19] - The company plans to enhance product adaptability through continuous hardware and software upgrades, focusing on optimizing the UP series and launching new flexible hardware products[21] - A new generation of intelligent scheduling system based on an Agent architecture will be developed, featuring environmental awareness and autonomous decision-making capabilities[21] Financial Position and Assets - The total assets increased from RMB 510.9 million as of December 31, 2024, to RMB 1,054.8 million as of December 31, 2025, while total liabilities decreased from RMB 2,029.6 million to RMB 194.6 million during the same period[52] - The company's equity increased from a loss of RMB 1,518.7 million as of December 31, 2024, to RMB 860.2 million as of December 31, 2025, mainly due to the reclassification of redeemable liabilities to equity after the IPO[51] - The cash and cash equivalents as of December 31, 2025, were RMB 233.4 million, up from RMB 105.5 million as of December 31, 2024[53] - The current ratio improved significantly to 580.6% as of December 31, 2025, compared to 21.3% as of December 31, 2024[55] - The debt-to-asset ratio decreased dramatically from 397.2% as of December 31, 2024, to 18.4% as of December 31, 2025[52] Operational Challenges and Costs - The company's sales cost rose to RMB 187.9 million, a 35.8% increase from RMB 138.4 million in 2024[37] - Research and development expenses increased to RMB 62.2 million, an 8.3% rise from RMB 57.4 million in 2024[39] - Sales and marketing expenses surged to RMB 87.9 million, a 51.1% increase from RMB 58.2 million in 2024[40] - Employee costs increased to RMB 172.367 million in 2025 from RMB 130.183 million in 2024[82] - The cost of inventory for the year ending December 31, 2025, was RMB 145.423 million, up from RMB 106.214 million in 2024[83] Future Plans and Investments - The company aims to expand its global influence by increasing investments in international markets, particularly in developed regions and emerging markets, with Japan, Southeast Asia, and Hong Kong identified as priority expansion areas by 2026[24] - The company will invest in building a multi-agent workflow platform and a company-level knowledge base to enhance operational efficiency and intelligence by 2026[25] - A smart operation and maintenance system will be developed, utilizing real-time operational data from robots to monitor performance and optimize service efficiency[27] - The company plans to commercialize mobile robotic arms, focusing on automating linen handling processes in hotel settings, thereby extending service capabilities[23] - The company plans to continue expanding its market presence and investing in AI technologies to drive future growth[68] Compliance and Governance - The company has maintained compliance with corporate governance codes since its listing date, ensuring high standards of governance[100] - No significant legal proceedings or claims are pending against the company as of the announcement date[98]

Group 1 - In 2025, there were 116 new companies listed on A-shares and 119 on Hong Kong stocks, with sectors including AI chips, semiconductor materials, new energy vehicles, chain consumption, and innovative pharmaceuticals [2][3] - The article highlights the increasing presence of female founders and co-founders in these newly listed companies [3] Group 2 - Moore Threads, co-founded by Zhou Yuan, is a notable GPU startup that went public in December 2025 with an initial market value exceeding 300 billion RMB [5][7] - MiniMax, co-founded by Yuan Yeyi, became the fastest AI model company to complete an IPO in January 2026, with a market value of 2230.11 billion RMB [9][10] - Light Health Group, led by Yang Yin, transitioned from a crowdfunding platform to a digital health service provider, achieving a market value of 157.85 billion RMB after its IPO [15][18] - Aixin Yuan Zhi, founded by Qiu Xiaoxin, became the first Chinese edge AI chip company to go public, with a market value of 146.31 billion RMB [20][23] - Baiao Saitou, co-founded by Ni Jian, went public on the STAR Market with a market value of 346.35 billion RMB, focusing on biopharmaceuticals [25][26] - Muxi Co., Ltd., co-founded by Peng Li, is another GPU company that went public in December 2025, with a market value of 2135.41 billion RMB [30][32] - Baoji Pharmaceutical, co-founded by Wang Zheng, achieved a market value of 291.44 billion RMB after its IPO, focusing on gene-engineered drugs [36][38] - Yunji Technology, founded by Zhi Tao, became the first company in the robot service sector to go public, with a market value of 92.79 billion RMB [42][43] - Haibo Shichuang, with Xu Rui as the only female executive, is a leading provider of electrochemical energy storage solutions, listed on the STAR Market [45][46] - Xuan Zhu Biotech, led by Xu Yanjun, focuses on innovative drug development and went public with a market value of 228.60 billion RMB [48][51] Group 3 - The article emphasizes that the presence of women in entrepreneurial and management roles is growing, with many women becoming founders, partners, and core managers in various companies [53] - The narrative celebrates women's contributions to entrepreneurship, suggesting that their impact extends beyond traditional roles [54]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 北京雲迹科技股份有限公司 呈交日期: 2026年3月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02670 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 62,599,638 | RMB | | 1 | RMB | | 62,599,638 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 62,599,638 | RMB | | 1 | RMB | | 62,599,638 | | 2. 股份分類 | 普通股 | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 Beijing Yunji Technology Co., Ltd. 中國北京，2026年3月3日 北京雲迹科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2670） 董事會召開日期 北京雲迹科技股份有限公司（「本公司」及其附屬公司「本集團」）董事會（「董事 會」）茲通告謹定於2026年3月13日（星期五）舉行本公司董事會會議，以考慮及酌 情通過本集團截至2025年12月31日止年度的全年業績公告，以及處理其他事項。 承董事會命 北京雲迹科技股份有限公司 董事長、執行董事兼總裁 支濤 截至本公告日期，本公司董事會包括：(i)執行董事支濤女士、胡泉先生及李全印 先生；(ii)非執行董事吳明輝先生；及(iii)獨立非執行董事張立華先生、黎勇越先 生及汪方軍先生。 ...